Literature DB >> 8318355

Neurohypophyseal peptides as regulators of growth and development. A review.

D A Carter1, C K Fai, D Murphy.   

Abstract

In addition to their classical hormonal role, the neurohypophyseal peptides vasopressin (AVP) and oxytocin (OT) are also implicated as regulators of growth and development. Mitogenic actions of AVP are particularly well characterized and may underly the potential role of AVP as an autocrine regulator of tumor growth. Effects of AVP and OT on neural development are suggested by numerous studies, but definitive physiological evidence is lacking. Current studies on the molecular characterization of AVP and OT receptors, and on transgenic animals will provide insights into the developmental actions of neurohypophyseal peptides.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8318355     DOI: 10.1007/BF02736686

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  58 in total

Review 1.  Primary response genes induced by growth factors and tumor promoters.

Authors:  H R Herschman
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

2.  Characterization of specific V1a vasopressin-binding sites on a rat mammary-tumour-cell line.

Authors:  G Guillon; C J Kirk; M N Balestre
Journal:  Biochem J       Date:  1986-11-15       Impact factor: 3.857

3.  Novel ligand specificity of pituitary vasopressin receptors in the rat.

Authors:  F A Antoni
Journal:  Neuroendocrinology       Date:  1984-08       Impact factor: 4.914

4.  Vasopressin inhibition of epidermal growth factor binding to cultured mouse cells.

Authors:  E Rozengurt; K D Brown; P Pettican
Journal:  J Biol Chem       Date:  1981-01-25       Impact factor: 5.157

5.  Vasopressin induces selective desensitization of its mitogenic response in Swiss 3T3 cells.

Authors:  M K Collins; E Rozengurt
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

6.  Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis.

Authors:  S Jard; R C Gaillard; G Guillon; J Marie; P Schoenenberg; A F Muller; M Manning; W H Sawyer
Journal:  Mol Pharmacol       Date:  1986-08       Impact factor: 4.436

7.  Induction of c-fos protein by activation of vasopressin receptors in smooth muscle cells.

Authors:  P Nambi; R Watt; M Whitman; N Aiyar; J P Moore; G I Evan; S Crooke
Journal:  FEBS Lett       Date:  1989-03-13       Impact factor: 4.124

8.  Corticotropin-releasing factor and vasopressin production in the rat pituitary tumor 7315a: biochemical and immunohistochemical studies.

Authors:  M I Morano; F E Estivariz
Journal:  Cancer Res       Date:  1989-05-15       Impact factor: 12.701

9.  Vasopressin: a potent growth factor in adrenal glomerulosa cells in culture.

Authors:  N Payet; Y Déziel; J G Lehoux
Journal:  J Steroid Biochem       Date:  1984-01       Impact factor: 4.292

10.  Increased amniotic vasopressin levels in experimentally growth-retarded rat fetuses.

Authors:  H P Oosterbaan; D F Swaab; G J Boer
Journal:  J Dev Physiol       Date:  1985-04
View more
  3 in total

1.  Developmental regulation of a local positive autocontrol of supraoptic neurons.

Authors:  V Chevaleyre; G Dayanithi; F C Moos; M G Desarmenien
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

2.  Interplay between presynaptic and postsynaptic activities is required for dendritic plasticity and synaptogenesis in the supraoptic nucleus.

Authors:  Vivien Chevaleyre; Francoise C Moos; Michel G Desarménien
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

3.  dDAVP Downregulates the AQP3-Mediated Glycerol Transport via V1aR in Human Colon HCT8 Cells.

Authors:  Mariangela Centrone; Mariagrazia D'Agostino; Marianna Ranieri; Maria Grazia Mola; Pinuccia Faviana; Piero Vincenzo Lippolis; Domenico Alessandro Silvestris; Maria Venneri; Annarita Di Mise; Giovanna Valenti; Grazia Tamma
Journal:  Front Cell Dev Biol       Date:  2022-07-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.